GTL001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GTL001, covering 2016-12-02 to 2016-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL [Phase 1]